BARDA purchases NUZYRA to treat anthrax infections

As part of ongoing national preparedness efforts, BARDA has purchased and begun accepting delivery of the antibiotic NUZYRA (omadacycline) from Paratek Pharmaceuticals of Boston, Massachusetts, to treat infections caused by anthrax.

The contract with Paratek was BARDA’s first

...

Continue Reading

Concerning news from the Consulate General of Spain in Shanghai

Yesterday, the Consulate General of Spain in Shanghai posted a notice on thier website containing some concerning news about the invlountary hospitalisation of foreign citizens living and/or arriving in China that have been vaccinated or overcome Covid in recent months. 

The

...

Continue Reading

Big news for D7 disinfectant!

Decon 7 are pleased to announce that their D7 disinfectant product was recently approved by the EPA to kill SARS-CoV-2 (coronavirus) in 60 seconds.*

"As we have learned over the past year, SARS-CoV-2 can be difficult to combat because it is almost always surrounded by bodily fluids and

...

Continue Reading

Unusual Influenzas

Recently we have seen reports of cases of avian and swine influenzas showing up in humans. This of course does happen from time to time, but we presently seem to have a bit of a rash of cases. 

From ...

Continue Reading

Virtual Summer Workshop on Pandemics and Global Health Security

COVID-19 has exposed just how unprepared governments, corporations, and societies are for a global pandemic. While the SARS-CoV-2 virus is only the most recent threat to global health security, it will certainly not be the last. Threats to global health security continue to evolve due to the

...

Continue Reading

BARDA exercises option for supply of additional smallpox vaccine

 Bavarian Nordic A/S have announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has exercised the final USD 12 million option

...

Continue Reading

15 million doses of COVID-19 vaccines ruined

Oringinally published by Poynter

 The first big question the public will ask is whether any of the 15 million doses of Johnson & Johnson’s vaccine that workers ruined in a manufacturing mistake made it to vaccination lines. The New York Times, which ...

Continue Reading

High demand for FAI air ambulance service with Epishuttle

FAIs air ambulance division has been operating at maximum capacity to meet the high number of requests for repatriation and medevac flights. Since March FAI has performed almost 70 flights of covid-19 patients in 47 countries with the single patient isolation and transport system

...

Continue Reading

FDA approves first treatment for Ebola

On October 14 the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric

...

Continue Reading

Turkmenistan to build new virology lab?

From Khronika Turkmenistana Website 14 Sep 2020

President [of Turkmenistan] Gurbanguly Berdimuhamedov visited the construction site of a sanatorium in Ak Bugday District's Bagabat village on 13 September. The construction of the sanatorium for 200 beds became known in autumn

...

Continue Reading

Second case of Novel Orthopoxvirus infection reported in Alaska

A second case of a novel orthopox, first detailed in 2015, has been reported in the the Fairbanks area of Alaska. 

Named Alaskapox, due to it's region of discovery, this orthopox is not yet known to cause sever malady and both of those suffering from the infection reported cases of

...

Continue Reading

Not Your Usual Bioweapon of Choice

In December 2019 reports emerged that a Utah woman had been arrested for possesion of a biological weapon. Janie Lynn Ridd, 50, was arrested whilst the case was being investigated by both federal and state authorities. 

According to the affidavit at the time “Through

...

Continue Reading

Two Large Contracts for Sanofi & GSK

Sanofi and GSK have recently been awarded two large contracts by both the US and EU.

Under Operation Warp Speed in the USA, Sanofi and GSK have been selected to supply 100 million doses of COVID-19 Vaccine.
The vaccine candidate, developed by Sanofi in partnership

...

Continue Reading

BARDA Procures Regeneron's Investigational Ebola Treatment

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human

...

Continue Reading

Engineers design a reusable, silicone rubber face mask

MIT News Office

The prototype mask, which includes an N95 filter, can be easily sterilized and worn many times.

Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks. Unlike N95

...

Continue Reading

Russia denies that super rich are getting the good vaccine!

By BBC Monitoring

A Russian Health Ministry official and research centres testing an experimental vaccine against Covid-19 have denied reports that the country's business and political leadership have been given early access to it outside of clinical trials. 

Continue Reading

Some decontamination processes damage N95 face masks

From University of Massachusetts Amherst

Certain methods of decontaminating medical face masks for repeated use during the COVID-19 pandemic appear to damage the masks' integrity and protective function, according to research by a University of Massachusetts Amherst environmental health

...

Continue Reading

Smiths Detection enters into agreement to acquire PathSensors

Smiths Detection today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environmental-testing company based in Baltimore, MD. The acquisition expands Smiths Detection’s sensing capabilities across the CBRNE (chemical, biological,

...

Continue Reading

INOVIO Receives $71 Million Contract From U.S. DOD

 INOVIO today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA® 3PSP smart device and the procurement of CELLECTRA® 2000 devices, which are

...

Continue Reading

Our Current Sponsors